Eugenol potentiates cisplatin anti‐cancer activity through inhibition of ALDH‐positive breast cancer stem cells and the NF‐κB signaling pathway

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2744|57|3|333-346

ISSN： 0899-1987

Source： Molecular Carcinogenesis, Vol.57, Iss.3, 2018-03, pp. : 333-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pro‐inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF‐κB activation

By  

Molecular Carcinogenesis, Vol. 57, Iss. 2, 2018-02 ,pp. : 235-242

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mesenchymal stem cells inhibit breast cancer cell migration and invasion through secretion of tissue inhibitor of metalloproteinase‐1 and ‐2

By  

Molecular Carcinogenesis, Vol. 899-1987, Iss. 10, 2015-10 ,pp. : 1214-1219

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mesenchymal stem cells inhibit breast cancer cell migration and invasion through secretion of tissue inhibitor of metalloproteinase‐1 and ‐2

By  

Molecular Carcinogenesis, Vol. 54, Iss. 10, 2015-10 ,pp. : 1214-1219

John Wiley & Sons Inc

Access to resources Recommend Favorite

SLC34A2 regulates miR‐25‐Gsk3β signaling pathway to affect tumor progression in gastric cancer stem cell‐like cells

By  

Molecular Carcinogenesis, Vol. 57, Iss. 3, 2018-03 ,pp. : 440-450

John Wiley & Sons Inc

Access to resources Recommend Favorite

MiR‐5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6

By  

Molecular Carcinogenesis, Vol. 57, Iss. 3, 2018-03 ,pp. : 419-428

John Wiley & Sons Inc

Access to resources Recommend Favorite